Cleared Special

K132068 - PHILIPS DXL 12/16-LEAD ECG ALGORITHM (FDA 510(k) Clearance)

Sep 2013
Decision
85d
Days
Class 2
Risk

K132068 is an FDA 510(k) clearance for the PHILIPS DXL 12/16-LEAD ECG ALGORITHM. This device is classified as a Electrocardiograph (Class II - Special Controls, product code DPS).

Submitted by Philips Medical Systems (Andover, US). The FDA issued a Cleared decision on September 26, 2013, 85 days after receiving the submission on July 3, 2013.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2340.

Submission Details

510(k) Number K132068 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2013
Decision Date September 26, 2013
Days to Decision 85 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DPS — Electrocardiograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2340

Similar Devices — DPS Electrocardiograph

All 10
MAC 7 Resting ECG Analysis System
K251670 · Ge Medical Systems Information Technologies, Inc. · Jan 2026
Masimo W1
K243305 · Masimo Corporation · Apr 2025
Masimo W1
K240229 · Masimo Corporation · Aug 2024
Masimo W1
K232512 · Masimo Corporation · Nov 2023
Electrocardiograph: SE-1200 Pro and SE-1201 Pro
K222902 · Edan Instruments, Inc. · Jul 2023
MAC 5 A4/ MAC 5 A5/ MAC 5 Lite Resting ECG Analysis System
K221321 · Ge Medical Systems Information Technologies, Inc. · Oct 2022